Shield Therapeutics plc ( SHIEF) - Key Metrics
SHIEF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.03 | $0 | $0 | $0 |
| 2025Q4 | $0.03 | -$0.01 | -$0.01 | -$0.01 |
| 2025Q2 | $0.02 | -$0.01 | $0 | $0.01 |
| 2024Q4 | $0.01 | -$0.01 | -$0.01 | $0 |
| 2024Q2 | $0.01 | -$0.01 | -$0.01 | $0 |
SHIEF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -9.52 |
| 2025Q4 | 0% | -4.74 |
| 2025Q2 | 0% | -1.07 |
| 2024Q4 | 0% | -1.23 |
| 2024Q2 | 0% | -0.56 |
SHIEF Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 0.83% | 0% |
| 2025Q4 | -8.39% | 0% |
| 2025Q2 | 20.44% | 0% |
| 2024Q4 | -5.55% | 0% |
| 2024Q2 | -10.49% | 0% |
SHIEF
Price: $0.07
52 week price:
Earnings Per Share: -0.02 USD
P/E Ratio: -7.06
Exchange: OQB
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 91.6 million